| Factor Information | |
|---|---|
| Data ID | 3643 |
| Factor | RSV hospitalisation rates in CHD of age <12 months |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To obtain population based RSV hospitalisation rates in children ,24 months of age with CHD. |
| p Value | 0.43 |
| Conclusion | RSV hospitalisation rates (per 100 child-years) in CHD patients aged ,6, ,12, 12–24, and ,24 months of age were 2.5 (95% CI 0.8 to 5.6), 2.0 (0.8 to 3.8), 0.5 (0.1 to 1.8), and 1.3 (0.6 to 2.3), respectively, and the relative risk (RR) in comparison with non-CHD patients was 1.4 (0.6 to 3.1), 1.6 (0.8 to 3.2), 2.7 (0.7 to 9.7), and 1.8 (1.0 to 3.3), respectively |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 15383442 |
| Year | 2015 |
| Title | Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | Children | |
| Source | patients | |
| Region | Bern, Switzerland | |
| Method | population based study | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD patients(Treatment) | Non-CHD patients(Control) |
| Number | N/A | N/A |
| Age | [2.1–19.4] months | [0.2–23.6] months |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 2.0 (95%CI=0.9- 3.8) | 1.2 (95%CI=1.1-1.3) |
